NBI
atai Life Sciences Has Been Selected for Addition to the NASDAQ Biotechnology Index
Ryan Allway December 13th, 2021 NEW YORK, Dec. 13, 2021 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced it has been selected for addition to the Nasdaq Biotechnology Index (Nasdaq: NBI), effective... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )